27.02.2024 - PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) - Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will ...